Puma Biotechnology (PBYI) Tax Provisions (2020 - 2026)
Puma Biotechnology (PBYI) posted Tax Provisions of $326000.0 for Q1 2026, up 33.06% on a QoQ basis from $245000.0 in Q4 2025, and up 11.26% year-over-year from $293000.0 in Q1 2025.
Puma Biotechnology (PBYI) Tax Provisions (2020 - 2026) Analysis & Trends
Puma Biotechnology's Tax Provisions history runs 7 years deep, the most recent figure standing at $326000.0 for Q1 2026.
- Quarterly Tax Provisions rose 11.26% year-over-year to $326000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 416.13% YoY) and the FY2025 annual result came in at $1.2 million, up 612.57% from the prior year.
- Tax Provisions was $326000.0 for Q1 2026 at Puma Biotechnology, up from $245000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $399000.0 in Q3 2025 and bottomed at -$714000.0 in Q4 2024.
- A 5-year average of $156058.8 and a median of $220000.0 in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions soared 322.36% — and 2024, when it plunged 299.44%.
- Puma Biotechnology's Tax Provisions stood at -$161000.0 in 2022, then surged by 322.36% to $358000.0 in 2023, then plunged by 299.44% to -$714000.0 in 2024, then soared by 134.31% to $245000.0 in 2025, then soared by 33.06% to $326000.0 in 2026.
- Business Quant data shows PBYI's Tax Provisions at $326000.0 in Q1 2026, $245000.0 in Q4 2025, and $399000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Puma Biotechnology | 406.51 Mn | 368.22 Mn | 34.39 Mn | 326,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 326,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 310,000.00 |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | -714,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 378,000.00 |
| Mar 31, 2024 | 220,000.00 |
| Dec 31, 2023 | 358,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 187,000.00 |
| Mar 31, 2023 | 147,000.00 |
| Dec 31, 2022 | -161,000.00 |
| Sep 30, 2022 | 67,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Mar 31, 2022 | 37,000.00 |
| Dec 31, 2021 | 212,000.00 |
| Sep 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 38,000.00 |